(Q38077707)

28 August 2017

1 reference

title

When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? (English)

1 reference

Fluorodeoxyglucose Positron Emission Tomography

28 August 2017

main subject

1 reference

4

Abass Alavi

1 reference

28 August 2017

3

Hongming Zhuang

1 reference

28 August 2017

2

Drew A Torigian

1 reference

28 August 2017

Gang Cheng

1

1 reference

28 August 2017

publication date

30 January 2013

1 reference

28 August 2017

number of pages

9

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

28 August 2017

volume

40

1 reference

28 August 2017

issue

5

1 reference

28 August 2017

page(s)

779-787

1 reference

Review of Clinical Applications of Fluorodeoxyglucose-PET/Computed Tomography in Pediatric Patients with Lymphoma

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Detection of Hepatic Metastases Using Dual-Time-Point FDG PET/CT Scans in Patients with Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual-time-point F-18 FDG PET/CT for evaluation in patients with malignant lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

18F-FDG PET for the lymph node staging of non-small cell lung cancer in a tuberculosis-endemic country: is dual time point imaging worth the effort?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Assessment of dual-time-point 18F-FDG-PET imaging for pulmonary lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual-time point positron emission tomography findings of benign mediastinal lymph nodes in a tuberculosis-endemic region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Prognostic value of dual-time-point 18F-fluorodeoxyglucose positron emission tomography in patients with pulmonary sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Multimodality FDG PET/CT appearance of pulmonary tuberculoma mimicking lung cancer and pathologic correlation in a tuberculosis-endemic country.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual-time-point FDG-PET/CT for the detection of hepatic metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Are dual-phase 18F-FDG PET scans necessary in nasopharyngeal carcinoma to assess the primary tumour and loco-regional nodes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Limited predictive value of dual-time-point F-18 FDG PET/CT for evaluation of pathologic N1 status in NSCLC patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual-time-point fluorodeoxyglucose positron emission tomography for diagnosis of cervical lymph node metastases in patients with head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Limited prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stage I & II) non-small cell lung cancer (NSCLC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual-time point 18F-FDG PET/CT scan for differentiation between 18F-FDG-avid non-small cell lung cancer and benign lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

The role of dual time point FDG PET imaging in the evaluation of solitary pulmonary nodules with an initial standard uptake value less than 2.5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Differentiation of FDG-avid loco-regional recurrent and compromised benign lesions after surgery for breast cancer with dual-time point F-18-fluorodeoxy-glucose PET/CT scan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

The efficacy of dual time point F-18 FDG PET imaging for grading of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Advantage of delayed whole-body FDG-PET imaging for tumour detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual-phase FDG-PET: delayed acquisition improves hepatic detectability of pathological uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Optimizing delayed scan time for FDG PET: comparison of the early and late delayed scan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual time point FDG-PET/CT imaging... Potential tool for diagnosis of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Suture granuloma showing false-positive finding on PET/CT after head and neck cancer surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

FDG PET/CT imaging in granulomatous changes secondary to breast silicone injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Case report: Gluteal injection site granulomas: false positive finding on FDG-PET in patients with non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

False-positive positron-emission tomography-CT of a Teflon granuloma in the parapharyngeal space occurring after treatment for a patulous eustachian tube

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Multiple abdominal granuloma caused by spilled gallstones with imaging findings that mimic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

F-18 FDG PET-CT findings of intraperitoneal carbon particles-induced granulomas mimicking peritoneal carcinomatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Pleural granuloma mimicking malignancy 42 years after slurry talc injection for primary spontaneous pneumothorax

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

F-18 FDG PET of foreign body granuloma: pathologic correlation with imaging features in 3 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Xanthogranulomatous cholecystitis mimicking gallbladder carcinoma with a false-positive result on fluorodeoxyglucose PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

FDG PET/CT demonstrated rapid progression of mediastinal lymphadenopathy in sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Imaging features of sarcoidosis on MDCT, FDG PET, and PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Imaging characteristics of extrapulmonary tuberculosis lesions on dual time point imaging (DTPI) of FDG PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Improvement in sensitivity with delayed imaging of pulmonary lesions with FDG-PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Quantifying heterogeneity in human tumours using MRI and PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Imaging of primary breast cancer with 18F-fluorodeoxythymidine PET-CT reveals heterogeneity of proliferation throughout the tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Spatial heterogeneity of low-grade gliomas at the capillary level: a PET study on tumor blood flow and amino acid uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Impact of tumor size and tracer uptake heterogeneity in (18)F-FDG PET and CT non-small cell lung cancer tumor delineation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3 h.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Accuracy of FDG-PET to diagnose lung cancer in a region of endemic granulomatous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Positron emission tomography imaging in nonmalignant thoracic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Value of delayed 18F-FDG-PET imaging in the detection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Comparison of early and delayed FDG PET for evaluation of biliary stricture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Limited diagnostic and predictive values of dual-time-point 18F FDG PET/CT for differentiation of incidentally detected thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-013-2343-9

Optimum scanning protocol for FDG-PET evaluation of pulmonary malignancy.

21 January 2018

1 reference

12 December 2020

[Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer]

1 reference

12 December 2020

18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter.

1 reference

12 December 2020

Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck

1 reference

12 December 2020

Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals

1 reference

12 December 2020

Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0.

1 reference

12 December 2020

FDG-PET in oncology: there's more to it than looking at pictures

1 reference

12 December 2020

Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.

1 reference

12 December 2020

Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma.

1 reference

12 December 2020

Implications of standardized uptake value measurements of the primary lesions in proven cases of breast carcinoma with different degree of disease burden at diagnosis: does 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography predict tumor

1 reference

12 December 2020

SUV on dual-phase FDG PET/CT correlates with the Ki-67 proliferation index in patients with newly diagnosed non-Hodgkin lymphoma

1 reference

12 December 2020

Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders

1 reference

12 December 2020

Impact of dual-time-point F-18 FDG PET/CT in the assessment of pleural effusion in patients with non-small-cell lung cancer

1 reference

12 December 2020

Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients

1 reference

12 December 2020

The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?

1 reference

12 December 2020

Dynamic changes of FDG uptake and clearance in normal tissues

1 reference

12 December 2020

Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes.

1 reference

12 December 2020

FDG PET/CT and MRI findings in a patient with focal xanthogranulomatous pyelonephritis mimicking cystic renal malignancy.

1 reference

12 December 2020

The use of dual-phase 18F-FDG PET in characterizing thyroid incidentalomas

1 reference

12 December 2020

Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.

1 reference

12 December 2020

Value of dual-time-point FDG PET/CT for mediastinal nodal staging in non-small-cell lung cancer patients with lung comorbidity

1 reference

12 December 2020

Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area.

1 reference

12 December 2020

SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences.

1 reference

12 December 2020

18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax.

1 reference

12 December 2020

Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET.

1 reference

12 December 2020

Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes

1 reference

12 December 2020

10.1007/S00259-013-2343-9

Identifiers

DOI

1 reference

28 August 2017

1 reference